TOOLKIT
Thank you for registering for POP-Q! Go beyond the workshop to learn more about managing Acute Myelogenous Leukemia with these resources below. You can also rewatch the program here.
FACULTY
UPDATES IN THE MANAGEMENT OF AML IN YOUNGER PATIENTS
- Anthracycline Cardiotoxicity Equivalence Calculator
- AML Pearls
- FDA–approved FLT3 Targeted Agents: Pediatric Focus
- COG Long-Term Follow-Up Guidelines, version 5.0 (2018)
- Additional References
- Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children with Relapsed AML.
- Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients with AML
- Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
PRE-EMPTIVE VS. INTERVENTIONAL USE OF DEFIBROTIDE TO MITIGATE SINUSOIDAL OBSTRUCTIVE SYNDROME (SOS)
- Organizational Guidance
- Diagnosis of SOS in Pediatric Patients
- Defibrotide
- Other Recommended Readings
MANAGEMENT OF THROMBOCYTOPENIA
- Immune Mediated Thrombocytopenia: References & Resources
- Transplant Associated Thrombotic Microangiopathy: References & Resources
IMMUNOTHERAPY IN THE MANAGEMENT OF AML
CE Synergy, LLC | Site by Big Picture Digital | Privacy Policy | Cookie Policy | Terms & Conditions | Careers |